HyperLabs transferred 1.875 million HYPE tokens to five over-the-counter (OTC) buyer wallets, each receiving 375,000 HYPE. This move represents half of a larger token allocation worth about $330 million, following a seven-day unstaking process of 3.75 million HYPE. The tokens were allocated through an OTC transaction rather than a public sale, giving traders a clear on-chain allocation to watch for possible selling pressure. However, there is no confirmation that these tokens will be sold on public exchanges, making this a key development for market participants to monitor.
HyperLabs' transfer of 1.875 million HYPE tokens to OTC buyers is noted here with Pluang market data as of Oct 07, 2026 23:32 WIB. For readers following major cryptocurrencies, 6 of 50 priced assets rose and 42 fell today on Pluang. Among movers, EOS gained 8.13% to Rp12.649, while SNX and VET declined by 7.66% and 7.24% respectively, with SNX showing a strong buy order activity of 98%.
BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...
Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...
Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...
Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...
Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...
